2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Glioblastoma
3
Esophageal Neoplasms
3
Recurrence
2
Esophageal Squamous Cell Carcinoma
2
Endometrial Neoplasms
2
Brain Neoplasms
2
Thyroid Neoplasms
1
Pathologic Complete Response
1
Oligodendroglioma
1
Lymphoma, Follicular
1
Lymphatic Metastasis
1
Li-Fraumeni Syndrome
1
Gliosarcoma
1
Glioma
1
Ependymoma
1
Disease
1
DWI-MRI
1
Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Astrocytoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Blood Specimen Collection
9
Surveys and Questionnaires
6
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Prednisone
5
Mammography
5
Colonoscopy
5
Biopsy
5
Positron Emission Tomography Computed Tomography
4
Magnetic Resonance Imaging
4
Lenalidomide
4
Biopsy, Fine-Needle
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surgical Procedures, Operative
3
Melphalan
3
Liquid Biopsy
3
Interviews as Topic
3
Exercise
3
Diagnostic Tests, Routine
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Urination
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Disease
×
Diffusion Magnetic Resonance Imaging
×
Clear all
NCT01836484
2020-02-13
MAPPING
Barts & The London NHS Trust
Completed
162 enrolled